Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 1,318,469	$ 2,173,258
Short term investments	0	1,651,341
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at June 30, 2016 and December 31, 2015	1,284,015	929,289
Inventories	1,910,729	1,834,635
Prepaid expenses and other current assets	402,342	384,414
Total current assets	4,915,555	6,972,937
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	652,941	557,666
Manufacturing and other equipment	1,029,600	1,025,521
Subtotal	2,967,032	2,867,678
Less: Accumulated depreciation	(1,605,173)	(1,421,279)
Net property and equipment	1,361,859	1,446,399
Internal use software	2,021,489	1,698,735
Intangible asset	2,215,385	2,215,385
Long term deposits	36,166	36,166
Total assets	10,550,454	12,369,622
Current liabilities
Accounts payable	864,452	1,029,373
Note payable, related party, net of discount of $343,191 at June 30, 2016	656,809	0
Accrued interest, related party	8,333	0
Accrued expenses and other current liabilities	80,037	146,438
Accrued compensation	523,694	419,766
Deferred rent	130,216	130,216
Total current liabilities	2,263,541	1,725,793
Deferred rent, long term	740,888	784,458
Total liabilities	3,004,429	2,510,251
Commitments and contingencies (Note 9)
Shareholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized, 12,607,055 and 12,448,391 shares issued and outstanding at June 30, 2016 and December 31, 2015	12,607	12,447
Additional paid-in capital	73,719,666	72,823,398
Accumulated other comprehensive loss	0	(451)
Accumulated deficit	(66,909,834)	(64,326,923)
Total BioLife Solutions, Inc. shareholders' equity	6,822,439	8,508,471
Total non-controlling interest equity	723,586	1,350,900
Total shareholders' equity	7,546,025	9,859,371
Total liabilities and shareholders' equity	$ 10,550,454	$ 12,369,622